Abstract
During the COVID-19 pandemic there was substantial variation between countries in the severity of the travel restrictions implemented suggesting a need for better importation models. Data to evaluate the accuracy of importation models is available for the Canadian province of Newfoundland and Labrador (NL; September 2020 to June 2021) as arriving travelers were frequently tested for SARS-CoV-2 and travel-related cases were reported. Travel volume to NL was estimated from flight data, and travel declaration forms completed at entry to Canada, and at entry to NL during the pandemic. We found that during the pandemic travel to NL decreased by 82%, the percentage of travelers arriving from Québec decreased (from 14 to 4%), and from Alberta increased (from 7 to 17%). We derived and validated an epidemiological model predicting the number of travelers testing positive for SARS-CoV-2 after arrival in NL, but found that statistical models with less description of SARS-CoV-2 epidemiology, and with parameters fitted from the validation data more accurately predicted the daily number of travel-related cases reported in NL originating from Canada (R2 = 0.55, ΔAICc = 137). Our results highlight the importance of testing travelers and reporting travel-related cases as these data are needed for importation models to support public health decisions.
Significance Importation models consider epidemiology and inbound travel volumes to predict the arrival rate of infected travelers to a jurisdiction, and are used to guide travel restriction recommendations during outbreaks. A limitation of many importation models are that they are not validated with ‘real world’ data. Using data from the province of Newfoundland and Labrador (NL), Canada, we develop an importation model that considers travel volumes estimated from travel declaration forms completed by arriving travelers, and SARS-CoV-2 epidemiology. We validate the model using the number of travel-related cases reported from September 2020 to May 2021 in NL. Our results highlight the importance of reporting travel-related cases, and the need for detailed travel and epidemiological data to formulate reliable importation models.
Competing Interest Statement
AH was a member of the Newfoundland and Labrador Predictive Analytics modelling team and previously received funding from the Newfoundland and Labrador Centre for Health Information.
Funding Statement
All authors were supported by funding from Mathematics for Public Health (560523-2020), the One Health Modelling Network for Emerging Infections (560520-2020), and by the Emerging Infectious Disease Modelling Consortium funded by the Natural Sciences and Engineering Council of Canada. AH and JA are supported by the Canadian Network for Modelling Infectious Diseases (560516-2020)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Health Research Ethics Board of Newfoundland and Labrador gave ethical approval for this work (reference number 2021.013)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data requiring ethics approval can be requested from the Newfoundland and Labrador Centre for Health Information. All publicly available data are archived online.
